Torecan
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors »
"The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved t"...
Read the FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors article »
Torecan
Please Note: This Brand Name drug is no longer available in the US.(Generic versions may still be available.)
DOSAGE AND ADMINISTRATION
Adult
Usual daily dose range is 10 mg to 30 mg.
Oral: One tablet, one to three times daily.
Intramuscular: 2 mL IM, one to three times daily. (See PRECAUTIONS.)
Pediatric Patients
Appropriate dosage of TORECAN (thiethylperazine) has not been determined in pediatric patients.
HOW SUPPLIED
Torecan (thiethylperazine maleate) Tablets, USP
- 10mg Each tablet contains 10 mg thiethylperazine maleate, USP.
- Bottles of 100 tablets (NDC 0054-4748-25).
Storage: Below 86°F (30°C). Dispense in tight, light-resistant container as defined in the USP/NE
Torecan (thiethylperazine malate) Injection, USP
2 mL Ampul
Storage: Below 86°F (30°C); protect from light. Administer only if clear and colorless.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Torecan Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.
Updated & New
